These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4749642)

  • 21. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevation of factor VIII in acute liver necrosis. Influence of plasmapheresis.
    Baele G; Vermeire P; Demeulenaere L; Barbier F
    Digestion; 1973; 8(4):360-7. PubMed ID: 4793123
    [No Abstract]   [Full Text] [Related]  

  • 23. [Factor VIII concentrate, highly purified and heated in solution (author's transl)].
    Heimburger N; Schwinn H; Gratz P; Lüben G; Kumpe G; Herchenhan B
    Arzneimittelforschung; 1981; 31(4):619-22. PubMed ID: 6788045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
    Farrugia A; Griffin B; Pepper D; Prowse C
    Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Jaundice and hepatitis B antigen-antibody in hemophilia.
    Lewis JH; Maxwell NG; Brandon JM
    Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal.
    Johnson AJ
    Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Factor-VIII concentrate and hepatitis.
    Dane DS; Cameron CH
    Lancet; 1975 Aug; 2(7929):328-9. PubMed ID: 50542
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparation and characterization of hepatitis B-antigen for radioimmunoassay.
    Skinhöj P; Hansen JF
    Scand J Clin Lab Invest; 1973 Nov; 32(3):199-203. PubMed ID: 4769050
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of factor VIII concentrates by cryoprecipitate sedimentation.
    Boudart DJ; Naud MF
    Transfusion; 1979; 19(5):594-6. PubMed ID: 505533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of cryoprecipitated factor VIII concentrates.
    Slichter SJ; Counts RB; Henderson R; Harker LA
    Transfusion; 1976; 16(6):616-26. PubMed ID: 996922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmapheresis for the preparation of HIV free cryoprecipitate.
    Tardtong P; Chuansumrit A; Stabanswadigan S; Chiewsilp P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():195-7. PubMed ID: 7886572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission of viral hepatitis, type B, by plasma derivatives.
    Barker LF; Hoofnagle JH
    Dev Biol Stand; 1974; 27():178-88. PubMed ID: 4142771
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].
    Grgicević D; Flego I; Marchiotti I; Lupret L; Rajninger-Miholić M
    Lijec Vjesn; 1990; 112(7-8):212-5. PubMed ID: 2127297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor VIII and factor VIIIa.
    Lollar P; Fay PJ; Fass DN
    Methods Enzymol; 1993; 222():128-43. PubMed ID: 8412790
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.